NERV - Minerva Neurosciences, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development30,255.89220,439.99418,533.363
Selling General and Administrative10,914.2699,750.7027,576.256
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-41,170.161-30,190.696-26,109.619
Income from Continuing Operations
Total Other Income/Expenses Net884.946175.05881.057
Earnings Before Interest and Taxes-40,285.215-30,015.638-26,028.562
Interest Expense614.2641,029.7341,053.07
Income Before Tax-40,899.479-31,045.372-27,081.632
Income Tax Expense-9,376.272--
Minority Interest---
Net Income From Continuing Ops-31,523.207-31,045.372-27,081.632
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-31,523.207-31,045.372-27,081.632
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-31,523.207-31,045.372-27,081.632